FAP and esophageal squamous cell carcinoma: Furthermore, we found out plasma FAPα can screen ESCC and improve the diagnosis of ESCC by combined with other traditional biomarkers, indicating that circulating FAPα was a potential indicator for the diagnosis of ESCC.